PTBP1 and osteosarcoma: In conclusion, the central findings of the current study present evidence indicating that ELK1 promotes the chemoresistance of osteosarcoma cells to DXR via downregulation of miR-134 and upregulation of PTBP1 (summarized in Figure 8).